External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder

Journal of Urology

Volumn 187, Issue 4, 2012, Pages 1210-1214

  May, Matthias ^a   Bastian, Patrick J ^b   Brookman May, Sabine ^c   Fritsche, Hans Martin ^c   Bolenz, Christian ^d   Gilfrich, Christian ^a   Otto, Wolfgang ^c   Trojan, Lutz ^d   Herrmann, Edwin ^e   Müller, Stefan C ^f   Ellinger, Jörg ^f   Buchner, Alexander ^b   Stief, Christian G ^b   Tilki, Derya ^b   Wieland, Wolf F ^c   Hohenfellner, Markus ^d   Haferkamp, Axel ^g   Roigas, Jan ^h   Zacharias, Mario ⁱ   Nuhn, Philipp ^b   Burger, Maximilian ^j   more..

^a Urologische Klinik   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f UNIVERSITY OF BONN   (Germany)

^g GOETHE UNIVERSITY   (Germany)

^h VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

ⁱ Vivantes Klinikum Auguste Viktoria Klinikum   (Germany)

^j UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

more..

Author keywords

carcinoma; Germany; mortality; urinary bladder; urothelium

Indexed keywords

ARTICLE; CANCER INVASION; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; CYSTECTOMY; DIAGNOSTIC ACCURACY; FOLLOW UP; HUMAN; INSTRUMENT VALIDATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DISEASE-FREE SURVIVAL; FORECASTING; HUMANS; MODELS, STATISTICAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK ASSESSMENT; URINARY BLADDER NEOPLASMS;

EID: 84858705818     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.11.104     Document Type: Article

References (13)

1. A. Stenzl, N.C. Cowan, M. De Santis Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines Eur Urol 59 2011 1009
2. D. Tilki, R.S. Svatek, P.I. Karakiewicz pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder J Urol 184 2010 470
3. P.J. Bastian, G.C. Hutterer, S.F. Shariat Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival Bladder Cancer Research Consortium BJU Int 101 2008 450
4. M.L. Quek, J.P. Stein, P.E. Clark Microscopic and gross extravesical extension in pathological staging of bladder cancer J Urol 171 2004 640
5. K.J. Boudreaux Jr, S.S. Chang, W.T. Lowrance Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes Cancer 115 2009 770
6. D.S. Kaufman, W.U. Shipley, A.S. Feldman Bladder cancer Lancet 374 2009 239
7. A.H. Feifer, J.M. Taylor, T.V. Tarin Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy Eur Urol 59 2011 978
8. P.I. Karakiewicz, S.F. Shariat, G.S. Palapattu Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder J Urol 176 2006 1354
9. B.H. Bochner, M.W. Kattan, K.C. Vora Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer International Bladder Cancer Nomogram Consortium J Clin Oncol 24 2006 3967
10. G. Sonpavde, M.M. Khan, R.S. Svatek Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy J Urol 185 2011 1216
11. C. Wittekind, H.J. Meyer, F. Bootz TNM Classification of Malignant Tumours 5th ed. 1997 Springer New York
12. F.K. Mostofi, I.A. Sesterhenn Pathology of epithelial tumors and carcinoma in situ of bladder Prog Clin Biol Res 162A 1984 55
13. M. May, H.M. Fritsche, C. Gilfrich Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: Survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder Urologe A 50 2011 821